Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

被引:31
作者
Bacci, G
Longhi, A
Barbieri, E
Ferrari, S
Mercuri, M
Briccoli, A
Versari, M
Pignotti, E
Picci, P
机构
[1] Ist Ortoped Rizzoli, Dept Chemotherapy, I-40136 Bologna, Italy
[2] St Orsola Hosp, Dept Radiotherapy, Bologna, Italy
[3] Ist Ortoped Rizzoli, Dept Orthopaed Surg, I-40136 Bologna, Italy
[4] Ist Ortoped Rizzoli, Dept Thorac Surg, I-40136 Bologna, Italy
[5] Ist Ortoped Rizzoli, Dept Stat, I-40136 Bologna, Italy
[6] Ist Ortoped Rizzoli, Dept Basic Res, I-40136 Bologna, Italy
关键词
Ewing sarcoma; second tumor; radiotherapy;
D O I
10.1097/01.mph.0000183270.28785.33
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relative risk of second tumors in patients with Ewing sarcoma is controversial, and little is known about their treatment and outcome. The purpose of the current study was to define the incidence and features of second tumors among 597 longterm survivors of norunetastatic Ewing sarcoma treated with adjuvant and neoadjuvant chemotherapy, radiotherapy, and/or surgery. The authors found that the risk of secondary malignancy after adjuvant or neoadjuvant treatment of Ewing sarcoma is higher than that after other childhood or adolescent cancers only after radiotherapy. Based on this, postoperative radiotherapy should be avoided when surgery with adequate margins is feasible.
引用
收藏
页码:517 / 520
页数:4
相关论文
共 29 条
[1]   Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute [J].
Bacci, G ;
Mercuri, M ;
Longhi, A ;
Bertoni, F ;
Barbieri, E ;
Donati, D ;
Giacomini, S ;
Bacchini, P ;
Pignotti, E ;
Forni, C ;
Ferrari, S .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) :2243-2251
[2]   Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Rimondini, S ;
Longhi, A ;
Bacchini, P ;
Forni, C ;
Manfrini, M ;
Donati, D ;
Picci, P .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :4-11
[3]  
BACCI G, 1982, CANCER-AM CANCER SOC, V48, P1561, DOI 10.1002/1097-0142(19820415)49:8<1561::AID-CNCR2820490808>3.0.CO
[4]  
2-K
[5]   High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group [J].
Bhatia, S ;
Yasui, Y ;
Robison, LL ;
Birch, JM ;
Bogue, MK ;
Diller, L ;
DeLaat, C ;
Fossati-Bellani, F ;
Morgan, E ;
Oberlin, O ;
Reaman, G ;
Ruymann, FB ;
Tersak, J ;
Meadows, AT .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4386-4394
[6]  
Boice J D Jr, 1985, Natl Cancer Inst Monogr, V68, P3
[7]   Second malignant neoplasms after a first cancer in childhood:: temporal pattern of risk according to type of treatment [J].
de Vathaire, F ;
Hawkins, M ;
Campbell, S ;
Oberlin, O ;
Raquin, MA ;
Schlienger, JY ;
Shamsaldin, A ;
Diallo, I ;
Bell, J ;
Grimaud, E ;
Hardiman, C ;
Lagrange, JL ;
Daly-Schveitzer, N ;
Panis, X ;
Zucker, JM ;
Sancho-Garnier, H ;
Eschwège, F ;
Chavaudra, J ;
Lemerle, J .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1884-1893
[8]   Second malignancies after treatment for Ewing's sarcoma:: A report of the CESS-studies [J].
Dunst, J ;
Ahrens, S ;
Paulussen, M ;
Rübe, C ;
Winkelmann, W ;
Zoubek, A ;
Harms, D ;
Jürgens, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02) :379-384
[9]   Ewing's sarcoma and the development of secondary malignancies [J].
Fuchs, B ;
Valenzuela, RG ;
Petersen, IA ;
Arndt, CA ;
Sim, FH .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (415) :82-89
[10]  
Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO